Global Malaria Treatment Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Dec 2020
  • Global
  • 350 Pages
  • No of Tables: 699
  • No of Figures: 79

Global Malaria Treatment Market, By Agent (Plasmodium Falciparum, P. Vivax, P. Ovale, P. Malariae and P. Knowlelsi), Type (Medication and Vaccination), Treatment Type (Suppressive Treatment and Radical Treatment), Drug Type (Branded and Generics), Route of Administration (Oral and Parenteral) End User (Hospitals, Specialty Clinics, Home Healthcare and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Nigeria, Democratic Republic of the Congo, Uganda, Mozambique, Niger, Côte d’Ivoire, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, Kuwait and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Malaria Treatment Market

Market Analysis and Insights: Global Malaria Treatment Market

Global malaria treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.1% in the forecast period of 2020 to 2027 and is expected to reach USD 8,90,834.96 thousand by 2027.

High prevalence and disease burden of malaria as well as increase in government initiation and expenditure for prevention of malaria are the major drivers which propelled the demand of the market in the forecast period.

Global malaria treatment market is growing tremendously across the globe due to the rise in medical insurance and additionally pandemic outbreak of coronavirus disease (COVID-19) across globe. The various categories of the medication malaria treatment include chloroquine, mefloquine, quinine, primaquine, hydroxychloroquine, artemisinin-based combination therapy (ACT), non-artemisinin based combinations (non-acts) and others. The increased research      and development activities lead to the increased product launch by key market players of the global malaria treatment market. However adverse effects and risks associated with anti-malaria may hamper the future growth of malaria treatment market.

The malaria treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Malaria Treatment Market

Global Malaria Treatment Market Scope and Market Size

Global malaria treatment market is categorized into seven notable segments which are based on the basis of agent, type, treatment type, drug type, route of administration, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core influencing areas and the difference in your target markets.

  • On the basis of agent, the malaria treatment market is segmented into plasmodium falciparum, P. vivax, P. ovale, P. malariae and P. knowlelsi. In 2020, plasmodium falciparum segment is dominating the malaria treatment market due to its rapid transmission. Additionally, climate condition and humidity of Sub-Saharan Africa is enhancing the transmission of malaria by the virtue of plasmodium falciparum.
  • On the basis of type, the malaria treatment market is segmented into medication and vaccination.  In 2020, vaccination medication segment is dominating the malaria treatment market as it is cost effective, easily accessible and is a primarily treatment for the malaria patient pool.
  • On the basis of treatment type, the malaria treatment market is segmented into suppressive treatment and radical treatment. In 2020, the suppressive treatment segment is dominating the malaria treatment market because it is considered to be the primary and fundamental treatment. Moreover, enormous demand of suppressive treatment worldwide acts as another driving factor for the malaria treatment market growth.
  • On the basis of drug type, the malaria treatment market is segmented into branded and generics.In 2020, generics segment is dominating the malaria treatment market because it is cost-effective in comparison to the branded drugs.
  • On the basis of route of administration, the malaria treatment market is segmented into oral and parenteral. In 2020, oral segment is dominating the malaria treatment market because it is considered to be the first line of therapy. Moreover, low manufacturing cost of tablets, capsules and other orally administered drugs act as another driving factor for the malaria treatment market growth. 
  • On the basis of end user, the malaria treatment market is segmented into hospitals, specialty clinics, home healthcare and others. In 2020, hospitals segment is dominating the malaria treatment market because of the increased healthcare expenditure by hospitals on advanced medical treatment.
  • On the basis of distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies and online pharmacies. In 2020, direct tender segment is dominating the malaria treatment market because direct tender holds the largest market share along with the highest CAGR because most of the service providers buy the product from manufacturers, and it is noticed that revenue from direct sales is higher; so it is influential as well as growing in the malaria treatment market.

Malaria Treatment Market

Malaria treatment Market Country Level Analysis

Malaria treatment market is analyzed and market size information is provided on the basis of agent, type, treatment type, drug type, route of administration, end user and distribution channel.

The countries covered in the Malaria treatment market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Nigeria, Democratic Republic of the Congo, Uganda, Mozambique, Niger, Côte d’Ivoire, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, Kuwait and Rest of Middle East and Africa.

Nigeria in Middle East and Africa region is expected to grow with the highest growth rate in the forecast period of 2020 to 2027 because of enormous prevalence of malaria vector-borne disease. Prevalence of malaria is enormous in the U.S., which is the dominating country in North America and usually impacts vulnerable populations every year. In India, there are regional zone where transmission of malaria is erratic or prone to epidemics; owing to climate, temperature and humidity, therefore the country is dominating in the Asia-Pacific region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Continuous Increasing Initiative Awareness Activities for Malaria Treatment are Boosting the Malaria Treatment Market Growth.

Malaria treatment market also provides you with detailed market analysis for every country growth in Malaria treatment industry. Moreover it provides the detail information of growing public-private partnership owing to initiative activities by healthcare organization. The data is available for historic period 2010 to 2018.

Competitive Landscape and Malaria Treatment Market Share Analysis

Malaria treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Malaria treatment market.

The major companies which are dealing in the Malaria treatment are Actiza Pharmaceutical Private Limited, AdvaCare Pharma, Amneal Pharmaceuticals LLC., Hikma Pharmaceuticals PLC, Ipca Laboratories Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Zydus Cadila,  Cipla Inc., Bliss GVS Pharma Ltd., GeoVax, MMV, Novartis AG, Sumaya Biotech, Taj Pharmaceuticals Limited, VLP Therapeutics, OSIVAX, Lupin Pharmaceuticals, Inc. (a subsidiary of LUPIN), Inc., AJANTA PHARMA, Strides Pharma Science Limited, sanofi-aventis U.S. LLC (a subsidiary of Sanofi), among others.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the malaria treatment market.

  • In August 2017, Novartis and Medicines for Malaria Venture (MMV) have declared a patient study for KAF156, the next generation of anti-inflammatory rheumatic compounds with the potential to treat drug-intolerant strains of the malaria parasite. The experiment has tested the activity of KAF156 together with a new, improved combination of existing anti-malarial malaria cases.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the malaria treatment market which also provides the benefit for organization to improve their offering for malaria treatment.

Customization Available: Global Malaria Treatment Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES 

TABLE 1 GLOBAL MALARIA TREATMENT MARKET, PIPELINE ANALYSIS

TABLE 2 FDA REQUIRES THE FOLLOWING SCENARIO BEFORE A DRUG IS APPROVED

TABLE 3 ESTIMATED MALARIA CASES AND DEATHS BY REGION, 2018

TABLE 4 FUTURE VECTOR CARE - FUTURE GENERALI (MALARIA CARE FAMILY HEALTH PLAN)

TABLE 5 REGULATORY CHALLENGES TO ANTIMALARIAL DRUG APPROVAL.

TABLE 6 CHALLENGES AND PROBLEMS THAT DRIVE THE R&D FRAMEWORK

TABLE 7 GLOBAL MALARIA TREATMENT MARKET, BY AGENT 2019-2027 (USD THOUSAND)

TABLE 8 GLOBAL PLASMODIUM FALCIPARUM IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)

TABLE 9 GLOBAL P. VIVAX IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)

TABLE 10 GLOBAL P. OVALE IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)

TABLE 11 GLOBAL P. MALARIAE IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)

TABLE 12 GLOBAL P. KNOWLELSI IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)

TABLE 13 GLOBAL MALARIA TREATMENT MARKET, BY TYPE 2019-2027 (USD THOUSAND)

TABLE 14 GLOBAL MEDICATION IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)

TABLE 15 GLOBAL MEDICATION IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 16 GLOBAL ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 17 GLOBAL NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 18 GLOBAL VACCINE IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)

TABLE 19 GLOBAL VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 20 GLOBAL MALARIA TREATMENT MARKET, BY TREATMENT TYPE 2019-2027 (USD THOUSAND)

TABLE 21 GLOBAL SUPPRESSIVE TREATMENT IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 22 GLOBAL RADICAL TREATMENT IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 23 GLOBAL MALARIA TREATMENT MARKET, BY DRUG TYPE 2019-2027 (USD THOUSAND)

TABLE 24 GLOBAL GENERICS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 25 GLOBAL BRANDED IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 26 GLOBAL BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 27 GLOBAL MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2019-2027 (USD THOUSAND)

TABLE 28 GLOBAL ORAL IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 29 GLOBAL PARENTERAL IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 30 GLOBAL PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 31 GLOBAL MALARIA TREATMENT MARKET, BY END USER 2019-2027 (USD THOUSAND)

TABLE 32 GLOBAL HOSPITALS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 33 GLOBAL SPECIALTY CLINICS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 34 GLOBAL HOME HEALTHCARE IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 35 GLOBAL OTHERS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 36 GLOBAL MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2027 (USD THOUSAND)

TABLE 37 GLOBAL DIRECT TENDER IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)

TABLE 38 GLOBAL HOSPITAL PHARMACIES IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 39 GLOBAL RETAIL PHARMACIES IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 40 GLOBAL ONLINE PHARMACIES IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 41 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY REGION 2018-2027 (USD THOUSAND)

TABLE 42 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 43 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 44 MIDDLE EAST & AFRICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 45 MIDDLE EAST & AFRICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 46 MIDDLE EAST & AFRICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 47 MIDDLE EAST & AFRICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 48 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 49 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 50 MIDDLE EAST & AFRICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 51 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 52 MIDDLE EAST & AFRICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 53 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 54 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 55 NIGERIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 56 NIGERIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 57 NIGERIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 58 NIGERIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 59 NIGERIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 60 NIGERIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 61 NIGERIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 62 NIGERIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 63 NIGERIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 64 NIGERIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 65 NIGERIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 66 NIGERIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 67 NIGERIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 68 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 69 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 70 DEMOCRATIC REPUBLIC OF THE CONGO MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 71 DEMOCRATIC REPUBLIC OF THE CONGO ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 72 DEMOCRATIC REPUBLIC OF THE CONGO NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 73 DEMOCRATIC REPUBLIC OF THE CONGO VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 74 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 75 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 76 DEMOCRATIC REPUBLIC OF THE CONGO BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 77 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 78 DEMOCRATIC REPUBLIC OF THE CONGO PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 79 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 80 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 81 UGANDA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 82 UGANDA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 83 UGANDA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 84 UGANDA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 85 UGANDA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 86 UGANDA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 87 UGANDA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 88 UGANDA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 89 UGANDA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 90 UGANDA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 91 UGANDA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 92 UGANDA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 93 UGANDA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 94 MOZAMBIQUE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 95 MOZAMBIQUE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 96 MOZAMBIQUE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 97 MOZAMBIQUE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 98 MOZAMBIQUE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 99 MOZAMBIQUE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 100 MOZAMBIQUE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 101 MOZAMBIQUE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 102 MOZAMBIQUE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 103 MOZAMBIQUE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 104 MOZAMBIQUE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 105 MOZAMBIQUE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 106 MOZAMBIQUE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 107 NIGER MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 108 NIGER MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 109 NIGER MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 110 NIGER ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 111 NIGER NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 112 NIGER VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 113 NIGER MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 114 NIGER MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 115 NIGER BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 116 NIGER MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 117 NIGER PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 118 NIGER MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 119 NIGER MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 120 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 121 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 122 CÔTE D’IVOIRE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 123 CÔTE D’IVOIRE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 124 CÔTE D’IVOIRE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 125 CÔTE D’IVOIRE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 126 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 127 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 128 CÔTE D’IVOIRE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 129 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 130 CÔTE D’IVOIRE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 131 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 132 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 133 SOUTH AFRICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 134 SOUTH AFRICA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 135 SOUTH AFRICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 136 SOUTH AFRICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 137 SOUTH AFRICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 138 SOUTH AFRICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 139 SOUTH AFRICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 140 SOUTH AFRICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 141 SOUTH AFRICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 142 SOUTH AFRICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 143 SOUTH AFRICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 144 SOUTH AFRICA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 145 SOUTH AFRICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 146 SAUDI ARABIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 147 SAUDI ARABIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 148 SAUDI ARABIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 149 SAUDI ARABIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 150 SAUDI ARABIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 151 SAUDI ARABIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 152 SAUDI ARABIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 153 SAUDI ARABIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 154 SAUDI ARABIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 155 SAUDI ARABIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 156 SAUDI ARABIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 157 SAUDI ARABIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 158 SAUDI ARABIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 159 UAE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 160 UAE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 161 UAE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 162 UAE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 163 UAE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 164 UAE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 165 UAE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 166 UAE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 167 UAE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 168 UAE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 169 UAE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 170 UAE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 171 UAE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 172 ISRAEL MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 173 ISRAEL MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 174 ISRAEL MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 175 ISRAEL ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 176 ISRAEL NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 177 ISRAEL VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 178 ISRAEL MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 179 ISRAEL MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 180 ISRAEL BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 181 ISRAEL MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 182 ISRAEL PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 183 ISRAEL MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 184 ISRAEL MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 185 EGYPT MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 186 EGYPT MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 187 EGYPT MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 188 EGYPT ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 189 EGYPT NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 190 EGYPT VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 191 EGYPT MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 192 EGYPT MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 193 EGYPT BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 194 EGYPT MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 195 EGYPT PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 196 EGYPT MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 197 EGYPT MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 198 KUWAIT MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 199 KUWAIT MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 200 KUWAIT MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 201 KUWAIT ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 202 KUWAIT NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 203 KUWAIT VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 204 KUWAIT MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 205 KUWAIT MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 206 KUWAIT BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 207 KUWAIT MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 208 KUWAIT PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 209 KUWAIT MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 210 KUWAIT MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 211 REST OF MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 212 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY REGION 2018-2027 (USD THOUSAND)

TABLE 213 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 214 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 215 ASIA-PACIFIC MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 216 ASIA-PACIFIC ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 217 ASIA-PACIFIC NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 218 ASIA-PACIFIC VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 219 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 220 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 221 ASIA-PACIFIC BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 222 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 223 ASIA-PACIFIC PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 224 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 225 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 226 INDIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 227 INDIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 228 INDIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 229 INDIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 230 INDIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 231 INDIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 232 INDIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 233 INDIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 234 INDIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 235 INDIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 236 INDIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 237 INDIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 238 INDIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 239 INDONESIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 240 INDONESIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 241 INDONESIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 242 INDONESIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 243 INDONESIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 244 INDONESIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 245 INDONESIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 246 INDONESIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 247 INDONESIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 248 INDONESIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 249 INDONESIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 250 INDONESIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 251 INDONESIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 252 SOUTH KOREA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 253 SOUTH KOREA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 254 SOUTH KOREA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 255 SOUTH KOREA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 256 SOUTH KOREA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 257 SOUTH KOREA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 258 SOUTH KOREA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 259 SOUTH KOREA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 260 SOUTH KOREA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 261 SOUTH KOREA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 262 SOUTH KOREA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 263 SOUTH KOREA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 264 SOUTH KOREA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 265 THAILAND MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 266 THAILAND MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 267 THAILAND MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 268 THAILAND ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 269 THAILAND NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 270 THAILAND VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 271 THAILAND MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 272 THAILAND MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 273 THAILAND BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 274 THAILAND MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 275 THAILAND PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 276 THAILAND MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 277 THAILAND MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 278 PHILIPPINES MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 279 PHILIPPINES MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 280 PHILIPPINES MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 281 PHILIPPINES ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 282 PHILIPPINES NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 283 PHILIPPINES VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 284 PHILIPPINES MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 285 PHILIPPINES MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 286 PHILIPPINES BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 287 PHILIPPINES MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 288 PHILIPPINES PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 289 PHILIPPINES MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 290 PHILIPPINES MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 291 VIETNAM MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 292 VIETNAM MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 293 VIETNAM MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 294 VIETNAM ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 295 VIETNAM NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 296 VIETNAM VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 297 VIETNAM MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 298 VIETNAM MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 299 VIETNAM BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 300 VIETNAM MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 301 VIETNAM PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 302 VIETNAM MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 303 VIETNAM MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 304 JAPAN MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 305 JAPAN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 306 JAPAN MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 307 JAPAN ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 308 JAPAN NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 309 JAPAN VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 310 JAPAN MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 311 JAPAN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 312 JAPAN BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 313 JAPAN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 314 JAPAN PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 315 JAPAN MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 316 JAPAN MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 317 AUSTRALIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 318 AUSTRALIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 319 AUSTRALIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 320 AUSTRALIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 321 AUSTRALIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 322 AUSTRALIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 323 AUSTRALIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 324 AUSTRALIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 325 AUSTRALIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 326 AUSTRALIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 327 AUSTRALIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 328 AUSTRALIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 329 AUSTRALIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 330 SINGAPORE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 331 SINGAPORE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 332 SINGAPORE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 333 SINGAPORE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 334 SINGAPORE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 335 SINGAPORE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 336 SINGAPORE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 337 SINGAPORE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 338 SINGAPORE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 339 SINGAPORE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 340 SINGAPORE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 341 SINGAPORE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 342 SINGAPORE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 343 CHINA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 344 CHINA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 345 CHINA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 346 CHINA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 347 CHINA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 348 CHINA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 349 CHINA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 350 CHINA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 351 CHINA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 352 CHINA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 353 CHINA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 354 CHINA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 355 CHINA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 356 MALAYSIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 357 MALAYSIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 358 MALAYSIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 359 MALAYSIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 360 MALAYSIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 361 MALAYSIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 362 MALAYSIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 363 MALAYSIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 364 MALAYSIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 365 MALAYSIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 366 MALAYSIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 367 MALAYSIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 368 MALAYSIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 369 REST OF ASIA-PACIFIC MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 370 SOUTH AMERICA MALARIA TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)

TABLE 371 SOUTH AMERICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 372 SOUTH AMERICA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 373 SOUTH AMERICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 374 SOUTH AMERICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 375 SOUTH AMERICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 376 SOUTH AMERICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 377 SOUTH AMERICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 378 SOUTH AMERICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 379 SOUTH AMERICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 380 SOUTH AMERICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 381 SOUTH AMERICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 382 SOUTH AMERICA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 383 SOUTH AMERICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 384 BRAZIL MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 385 BRAZIL MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 386 BRAZIL MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 387 BRAZIL ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 388 BRAZIL NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 389 BRAZIL VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 390 BRAZIL MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 391 BRAZIL MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 392 BRAZIL BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 393 BRAZIL MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 394 BRAZIL PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 395 BRAZIL MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 396 BRAZIL MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 397 PERU MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 398 PERU MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 399 PERU MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 400 PERU ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 401 PERU NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 402 PERU VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 403 PERU MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 404 PERU MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 405 PERU BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 406 PERU MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 407 PERU PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 408 PERU MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 409 PERU MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 410 ARGENTINA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 411 ARGENTINA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 412 ARGENTINA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 413 ARGENTINA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 414 ARGENTINA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 415 ARGENTINA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 416 ARGENTINA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 417 ARGENTINA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 418 ARGENTINA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 419 ARGENTINA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 420 ARGENTINA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 421 ARGENTINA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 422 ARGENTINA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 423 REST OF SOUTH AMERICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 424 EUROPE MALARIA TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)

TABLE 425 EUROPE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 426 EUROPE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 427 EUROPE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 428 EUROPE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 429 EUROPE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 430 EUROPE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 431 EUROPE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 432 EUROPE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 433 EUROPE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 434 EUROPE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 435 EUROPE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 436 EUROPE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 437 EUROPE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 438 GERMANY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 439 GERMANY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 440 GERMANY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 441 GERMANY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 442 GERMANY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 443 GERMANY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 444 GERMANY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 445 GERMANY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 446 GERMANY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 447 GERMANY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 448 GERMANY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 449 GERMANY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 450 GERMANY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 451 FRANCE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 452 FRANCE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 453 FRANCE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 454 FRANCE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 455 FRANCE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 456 FRANCE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 457 FRANCE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 458 FRANCE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 459 FRANCE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 460 FRANCE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 461 FRANCE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 462 FRANCE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 463 FRANCE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 464 ITALY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 465 ITALY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 466 ITALY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 467 ITALY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 468 ITALY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 469 ITALY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 470 ITALY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 471 ITALY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 472 ITALY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 473 ITALY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 474 ITALY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 475 ITALY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 476 ITALY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 477 U.K. MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 478 U.K. MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 479 U.K. MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 480 U.K. ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 481 U.K. NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 482 U.K. VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 483 U.K. MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 484 U.K. MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 485 U.K. BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 486 U.K. MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 487 U.K. PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 488 U.K. MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 489 U.K. MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 490 SPAIN MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 491 SPAIN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 492 SPAIN MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 493 SPAIN ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 494 SPAIN NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 495 SPAIN VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 496 SPAIN MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 497 SPAIN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 498 SPAIN BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 499 SPAIN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 500 SPAIN PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 501 SPAIN MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 502 SPAIN MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 503 NETHERLANDS MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 504 NETHERLANDS MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 505 NETHERLANDS MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 506 NETHERLANDS ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 507 NETHERLANDS NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 508 NETHERLANDS VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 509 NETHERLANDS MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 510 NETHERLANDS MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 511 NETHERLANDS BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 512 NETHERLANDS MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 513 NETHERLANDS PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 514 NETHERLANDS MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 515 NETHERLANDS MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 516 BELGIUM MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 517 BELGIUM MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 518 BELGIUM MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 519 BELGIUM ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 520 BELGIUM NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 521 BELGIUM VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 522 BELGIUM MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 523 BELGIUM MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 524 BELGIUM BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 525 BELGIUM MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 526 BELGIUM PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 527 BELGIUM MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 528 BELGIUM MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 529 RUSSIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 530 RUSSIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 531 RUSSIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 532 RUSSIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 533 RUSSIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 534 RUSSIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 535 RUSSIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 536 RUSSIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 537 RUSSIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 538 RUSSIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 539 RUSSIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 540 RUSSIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 541 RUSSIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 542 SWITZERLAND MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 543 SWITZERLAND MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 544 SWITZERLAND MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 545 SWITZERLAND ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 546 SWITZERLAND NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 547 SWITZERLAND VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 548 SWITZERLAND MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 549 SWITZERLAND MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 550 SWITZERLAND BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 551 SWITZERLAND MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 552 SWITZERLAND PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 553 SWITZERLAND MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 554 SWITZERLAND MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 555 AUSTRIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 556 AUSTRIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 557 AUSTRIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 558 AUSTRIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 559 AUSTRIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 560 AUSTRIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 561 AUSTRIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 562 AUSTRIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 563 AUSTRIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 564 AUSTRIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 565 AUSTRIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 566 AUSTRIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 567 AUSTRIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 568 IRELAND MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 569 IRELAND MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 570 IRELAND MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 571 IRELAND ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 572 IRELAND NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 573 IRELAND VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 574 IRELAND MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 575 IRELAND MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 576 IRELAND BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 577 IRELAND MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 578 IRELAND PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 579 IRELAND MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 580 IRELAND MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 581 TURKEY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 582 TURKEY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 583 TURKEY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 584 TURKEY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 585 TURKEY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 586 TURKEY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 587 TURKEY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 588 TURKEY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 589 TURKEY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 590 TURKEY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 591 TURKEY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 592 TURKEY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 593 TURKEY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 594 HUNGARY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 595 HUNGARY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 596 HUNGARY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 597 HUNGARY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 598 HUNGARY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 599 HUNGARY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 600 HUNGARY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 601 HUNGARY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 602 HUNGARY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 603 HUNGARY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 604 HUNGARY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 605 HUNGARY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 606 HUNGARY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 607 LITHUANIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 608 LITHUANIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 609 LITHUANIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 610 LITHUANIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 611 LITHUANIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 612 LITHUANIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 613 LITHUANIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 614 LITHUANIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 615 LITHUANIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 616 LITHUANIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 617 LITHUANIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 618 LITHUANIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 619 LITHUANIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 620 NORWAY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 621 NORWAY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 622 NORWAY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 623 NORWAY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 624 NORWAY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 625 NORWAY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 626 NORWAY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 627 NORWAY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 628 NORWAY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 629 NORWAY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 630 NORWAY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 631 NORWAY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 632 NORWAY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 633 POLAND MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 634 POLAND MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 635 POLAND MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 636 POLAND ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 637 POLAND NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 638 POLAND VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 639 POLAND MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 640 POLAND MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 641 POLAND BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 642 POLAND MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 643 POLAND PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 644 POLAND MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 645 POLAND MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 646 REST OF EUROPE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 647 NORTH AMERICA MALARIA TREATMENT MARKET, BY REGION 2018-2027 (USD THOUSAND)

TABLE 648 NORTH AMERICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 649 NORTH AMERICA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 650 NORTH AMERICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 651 NORTH AMERICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 652 NORTH AMERICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 653 NORTH AMERICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 654 NORTH AMERICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 655 NORTH AMERICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 656 NORTH AMERICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 657 NORTH AMERICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 658 NORTH AMERICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 659 NORTH AMERICA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 660 NORTH AMERICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 661 U.S. MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 662 U.S. MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 663 U.S. MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 664 U.S. ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 665 U.S. NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 666 U.S. VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 667 U.S. MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 668 U.S. MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 669 U.S. BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 670 U.S. MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 671 U.S. PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 672 U.S. MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 673 U.S. MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 674 MEXICO MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 675 MEXICO MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 676 MEXICO MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 677 MEXICO ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 678 MEXICO NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 679 MEXICO VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 680 MEXICO MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 681 MEXICO MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 682 MEXICO BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 683 MEXICO MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 684 MEXICO PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 685 MEXICO MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 686 MEXICO MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 687 CANADA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 688 CANADA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 689 CANADA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 690 CANADA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 691 CANADA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 692 CANADA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 693 CANADA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 694 CANADA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 695 CANADA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 696 CANADA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 697 CANADA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 698 CANADA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 699 CANADA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

 

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions